Sostanza(e)

• (1E,6E)-1,7-bis(3,4-dimethoxyphenyl)-4-cyclobutylmethyl-1,6-heptadiene-3,5-dione
• (E)-2-((2S,4S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-10-(carboxymethyl)-1-hydroxy-13-(2-(2-(2-((E)-3-(3-((3-hydroxy-3,3 diphosphonopropyl)(methyl)amino)propoxy)benzylidene)hydrazine-1-carbonothioyl)hydrazineyl)-2-oxoethyl)-8-oxo-5-thioxo-3,4,6,7,10,13-hexaazapentadec-2-en-15-oic acid
• 18-(p-(¹³¹I)-iodophenyl)octadecyl phosphocholine
• 5(S)-(2'-hydroxy ethoxy)-20(S)-camptothecin
• Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus
• Cisplatin (liposomal)
• Cisplatino complessato con lipidi
• Deforolimus
• Fenretinide
• Folinic acid
• Live attenuated bioengineered Listeria monocytogenes immunotherapy
• Methotrexate
• Mifamurtide
• Monoclonal antibody Hu3F8
• Rapamycin (mTOR) inhibitor
• haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate

Nome(i) commerciale(i)

• LEDERTREXATE
• LEUCOVORIN CALCIUM
• MEPACT
• METHOTREXATE WYETH LEDERLE